![Roberto Guerciolini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roberto Guerciolini
Plus aucun poste en cours
Profil
Roberto Guerciolini is the founder of Dicerna Pharmaceuticals, Inc. which was founded in 2007.
He held the title of SVP-Pharmaceutical Development from 2009 to 2013.
Dr. Guerciolini's former jobs include Senior Director-Clinical Pharmacology at Millennium Pharmaceuticals, Inc., Principal at Schering-Plough Corp., Chief Medical Officer & Senior Vice President at Sirna Therapeutics, Inc. from 2004 to 2006, Senior Vice President & Head-Early Development at Wave Life Sciences Ltd., and Principal at Hoffmann-La Roche, Inc. He was also a member of the American Board of Clinical Pharmacology, Inc. Dr. Guerciolini's education includes an MBA from the University of California, Berkeley and a doctorate from the University of Perugia.
Anciens postes connus de Roberto Guerciolini
| Sociétés | Poste | Fin |
|---|---|---|
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Directeur Technique/Scientifique/R&D | 05/10/2020 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/10/2006 |
| WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formation de Roberto Guerciolini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Perugia
 University of Perugia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Board of Clinical Pharmacology, Inc.
 American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services Operates health-related professional association | Commercial Services |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Health Technology |
